Candriam SCA’s GE HealthCare GEHC Stock Holding History

Candriam SCA’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Sell	21,571 -43,270	-67%	-$2.84M	0.01%	560
2026 Q1	$4.62M	Buy	64,841 +41,453	+177%	+$3.27M	0.02%	406
2025 Q4	$1.92M	Buy	23,388 +259	+1%	+$20.2K	0.01%	505
2025 Q3	$1.74M	Sell	23,129 -840	-4%	-$62.7K	0.01%	518
2025 Q2	$1.78M	Sell	23,969 -5,879	-20%	-$409K	0.01%	511
2025 Q1	$2.41M	Sell	29,848 -929	-3%	-$79.8K	0.02%	459
2024 Q4	$2.41M	Sell	30,777 -4,165	-12%	-$354K	0.01%	476
2024 Q3	$3.28M	Buy	34,942 +7,633	+28%	+$641K	0.02%	429
2024 Q2	$2.13M	Buy	27,309 +511	+2%	+$41.7K	0.01%	479
2024 Q1	$2.44M	Buy	26,798 +6,783	+34%	+$564K	0.02%	478
2023 Q4	$1.55M	Hold	20,015	–	–	0.01%	530
2023 Q3	$1.36M	Sell	20,015 -1,547	-7%	-$113K	0.01%	509
2023 Q2	$1.75M	Buy	21,562 +2,225	+12%	+$178K	0.01%	520
2023 Q1	$1.46M	Buy	+19,337	New	+$1.38M	0.01%	634

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Candriam SCA's GEHC Position: Q2 2026 in Review

Candriam SCA reduced its GE HealthCare (GEHC) stake by 67% in Q2 2026, selling an estimated $2.84M and leaving 21,571 shares worth $1.38M. The position accounts for 0.01% of the portfolio, ranked #560.

Candriam SCA first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.62M in Q1 2026. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Candriam SCA held 21,571 shares of GE HealthCare worth $1.38M as of Q2 2026.
Candriam SCA sold 43,270 GE HealthCare shares in Q2 2026, an estimated $2.84M.
GE HealthCare made up 0.01% of Candriam SCA's portfolio in Q2 2026, its #560 holding.
Candriam SCA first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
Candriam SCA's GE HealthCare position peaked at $4.62M in Q1 2026.
1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.